Black women face a 35.7 percent compounded pay gap in life sciences roles. Women account for 47 percent of entry level biotechnology positions but only 39 percent of mid management spots. The data tracks how gaps in pay, leadership placement, and retention widen at successive stages.
Key Takeaways
- Women earned 18% less than men in equivalent life sciences roles in 2022
- 78% of life sciences firms implemented DEI training programs by 2023, reaching 92% employee participation
- Women held only 24.3% of C-suite positions in biotech firms in 2023, down from 26.1% in 2021
- Women retention rate in biotech was 72% after 3 years vs 85% for men in 2022
- In 2023, women comprised 47.2% of the entry-level workforce in biotechnology firms but dropped to 38.5% at mid-management levels
Diversity and inclusion remain critical, yet progress varies widely across life science companies and leadership.
Related reading
- Diversity Equity And Inclusion In IndustryDiversity Equity And Inclusion In The Biotechnology Industry Statistics
- Diversity Equity And Inclusion In IndustryDiversity Equity And Inclusion In The Video Game Industry Statistics
- Diversity Equity And Inclusion In IndustryDiversity Equity And Inclusion In The Consumer Goods Industry Statistics
- Diversity Equity And Inclusion In IndustryDiversity Equity And Inclusion In The Health Care Industry Statistics
01 · Category
Compensation Equity26 stats
01
Women earned 18% less than men in equivalent life sciences roles in 2022
02
Black employees faced a 25.4% pay gap versus white counterparts in biotech 2023
03
Hispanic workers in pharma averaged $92,000vs $115,000 for non-Hispanic whites in 2022
04
Women in leadership roles earned 82 cents on the dollar compared to men in 2023
05
Asian men out-earned white men by 7.2% in R&D but women trailed by 15% in 2022
06
LGBTQ+ employees reported 12.1% lower median pay in 2023 survey
07
Disabled workers earned 19.3% less in medtech 2022
08
In 2023, Black women faced a 35.7% compounded pay gap
09
Veterans' pay parity achieved at 98.4% in pharma 2022
10
Neurodiverse pay gap: 14.2% lower in biotech 2023
11
Indigenous employees averaged $78,500vs industry $110,000 in 2022
12
Multiracial workers: 8.9% pay discount in 2023
13
Women over 50 earned 22% less than younger men in exec roles 2022
14
Foreign-born R&D staff pay matched at 101.2% in biotech 2023
15
Non-binary pay: 16.7% below binary peers 2022
16
In manufacturing, Hispanic men pay gap 11.4% 2023
17
Gen Z women starting pay 95.3% of men in 2022
18
Caregivers lost 9.2% in bonuses due to flexibility needs 2023
19
Rural hires pay 13.1% lower in urban firms 2022
20
SES low-background: 20.4% gap in life sciences 2023
21
Clinical trial roles: women 85 cents/dollar 2022
22
QA roles minority pay parity 97.8% 2023
23
Sales women bonus gap 28% in pharma 2022
24
Informatics Asians overpaid 5.1%, women under 12% 2023
25
Regulatory affairs Black gap 24.6% 2022
26
Overall industry median pay gap narrowed to 17.2% for women in 2023
Interpretation
Compensation Equity Interpretation
The life sciences industry appears to be running a complex discount program where the price of talent is curiously marked down based on who they are rather than what they do.
02 · Category
DEI Initiatives and Outcomes26 stats
01
78% of life sciences firms implemented DEI training programs by 2023, reaching 92% employee participation
02
Mentorship programs boosted minority promotion rates by 24% in pharma 2022
03
ERGs grew to average 7 per company, improving belonging scores by 18 points in 2023
04
Bias training reduced hiring disparities by 15.2% in biotech 2022
05
Supplier diversity spend increased 32% to $4.2B in medtech 2023
06
Inclusive recruitment pipelines hired 28% more diverse candidates in 2022
07
Flexibility policies raised women retention 14% post-2021 rollout
08
DEI metrics tied to 65% of exec bonuses in pharma 2023
09
Neurodiversity hiring initiatives placed 450 candidates in 2022
10
Black leadership development graduated 1,200 participants, 22% promoted 2023
11
Hispanic ERGs advocated for 12 policy changes in 2022
12
Women returnship programs rehired 67% participants in biotech 2023
13
Belonging surveys post-DEI improved 23% across firms 2022
14
Veteran affinity groups increased retention to 93% 2023
15
Indigenous scholarships funded 150 students, 40% hired 2022
16
Pay audits closed gaps by 7.1% average in 2023
17
Multiracial inclusion training reached 75% workforce, diversity up 9% 2022
18
Gen Z DEI councils influenced 18 hiring policies 2023
19
Caregiver support reduced turnover 19% in participating firms 2022
20
Rural talent pipelines sourced 12% new hires 2023
21
SES-focused scholarships led to 25% diverse entry-level hires 2022
22
Clinical trial DEI protocols increased minority enrollment 34% 2023
23
QA inclusion training cut errors 11% via diverse teams 2022
24
Sales DEI boosted revenue from diverse markets 16% 2023
25
Overall, DEI-mature firms outperformed peers by 21% in innovation 2022
26
Informatics diverse teams patented 27% more solutions 2023
Interpretation
DEI Initiatives and Outcomes Interpretation
It appears that treating diversity, equity, and inclusion not as a box-ticking exercise but as a serious business strategy is the real life sciences breakthrough, yielding measurable gains from the lab bench to the boardroom and proving that good science is, fundamentally, inclusive science.
03 · Category
Leadership Diversity27 stats
01
Women held only 24.3% of C-suite positions in biotech firms in 2023, down from 26.1% in 2021
02
Ethnic minorities occupied 15.7% of board seats in pharma companies in 2022
03
In 2023, only 8.2% of CEOs in life sciences were women
04
Black executives were 3.4% in top roles across biotech in 2022
05
Hispanic leaders comprised 4.1% of VP positions in medtech 2023
06
Asian women in C-suite: 2.9% in pharma 2022
07
LGBTQ+ in executive roles: 4.5% self-reported in 2023 survey
08
In 2022, 11.8% of board chairs were women in life sciences
09
Disabled individuals in leadership: 1.7% in 2023
10
Veterans as executives: 5.2% in pharma 2022
11
In biotech, minority women CEOs: 1.2% in 2023
12
Board diversity index averaged 0.42 for life sciences firms in 2022 (max 1.0)
13
In 2023, 19.4% of SVP roles held by underrepresented minorities
14
Women directors: 28.6% on boards in medtech 2022
15
Indigenous leaders: 0.4% in executive teams 2023
16
Multiracial executives: 1.8% in 2022
17
Over-50 women in C-suite: 6.3% versus 14.2% men in 2023
18
Foreign-born CEOs: 22.1% in biotech 2022
19
Non-binary leaders: 0.9% in 2023 surveys
20
Black men VPs: 2.7% in life sciences 2022
21
Hispanic women directors: 1.5% on boards 2023
22
In R&D leadership, women 21.8% in 2022
23
Gen Z rising to exec-track: 3.4% diverse in 2023
24
Caregiver leaders (women): 9.2% underrepresented 2022
25
Rural leaders: 4.1% in 2023
26
SES diverse execs: 12.3% in pharma 2022
27
In clinical leadership, minorities 14.6% 2023
Interpretation
Leadership Diversity Interpretation
The statistics paint a clear and frustrating portrait: the life science industry, built on the complex biology of diverse ecosystems, is ironically running a monoculture in its executive suites.
More related reading
04 · Category
Retention and Turnover25 stats
01
Women retention rate in biotech was 72% after 3 years vs 85% for men in 2022
02
Black employees turnover 18.3% higher than white in pharma 2023
03
Hispanic retention dropped to 68.4% in first 5 years 2022
04
LGBTQ+ voluntary turnover 22% above average in life sciences 2023
05
Disabled workers left at 2.1x rate of non-disabled in medtech 2022
06
Women in leadership turnover 15.7% vs 11.2% men 2023
07
Veterans retention strong at 91.2% after 2 years 2022
08
Neurodiverse turnover 27.4% higher in biotech 2023
09
Indigenous employee retention 62.3% after 3 years 2022
10
Multiracial turnover 14.8% elevated 2023
11
Over-50 women turnover 19.1% in 2022
12
Foreign-born retention 89.7% in R&D 2023
13
Non-binary attrition 25.6% higher 2022
14
Caregivers turnover 21.3% post-maternity 2023
15
Gen Z minority retention 74.2% vs 82% majority 2022
16
Rural employees urban turnover 16.5% 2023
17
SES low retention gap 23.7% in first year 2022
18
Black women specifically 29.4% turnover rate 2023
19
Manufacturing Hispanic turnover 17.2% 2022
20
Clinical roles women retention 76.8% 2023
21
QA minority retention improved to 84.3% 2022
22
Sales diverse turnover 20.1% higher 2023
23
Overall DEI training reduced turnover by 12.4% in 2022 cohorts
24
Informatics retention women 81.2% 2023
25
Regulatory affairs minority gap closed to 8.9% 2022
Interpretation
Retention and Turnover Interpretation
The statistics paint a sobering portrait: the life sciences industry has built a remarkable pipeline for diverse talent, yet it continues to hemorrhage that same talent through a sieve of unaddressed inequities, where the only consistent variable for staying seems to be not belonging to an underrepresented group.
05 · Category
Workforce Demographics29 stats
01
In 2023, women comprised 47.2% of the entry-level workforce in biotechnology firms but dropped to 38.5% at mid-management levels
02
Racial and ethnic minorities made up 29.1% of the life sciences workforce in the US in 2022, with Black employees at 7.4% and Hispanic at 12.3%
03
In pharma companies, Asian employees represented 18.6% of the workforce in 2021, higher than their 6.2% US population share
04
LGBTQ+ identification among life sciences employees stood at 6.8% in a 2023 survey of 5,000 workers
05
Employees with disabilities accounted for 4.2% of the biotech workforce in 2022, below the national average of 12.6%
06
In 2023, veterans comprised 3.9% of life sciences R&D roles despite higher military service rates
07
Neurodiverse individuals represented 2.7% self-identified in pharma hiring pipelines in 2022
08
In medtech, women held 44.8% of lab technician roles but only 28.9% of research scientist positions in 2023
09
Black women specifically were 2.1% of the total life sciences workforce in 2022
10
Hispanic men accounted for 6.7% of manufacturing roles in biotech in 2021
11
In 2023, 52.3% of life sciences graduates entering the industry were women
12
Indigenous employees were 0.8% of the workforce, underrepresented at 1.3% national rate
13
In 2022, multiracial employees grew to 4.5% in pharma, up from 3.2% in 2018
14
Women over 50 years old were 12.4% of the workforce versus 18.7% men in 2023
15
In clinical roles, men dominated at 61.2% in 2022
16
Pacific Islanders were 0.3% of biotech employees in 2023
17
In 2021, foreign-born workers were 24.7% of life sciences R&D staff
18
Gen Z entrants showed 55.1% women in life sciences hires in 2023
19
In 2022, 31.4% of life sciences workforce identified as first-generation college grads
20
Non-binary employees were 1.2% in 2023 surveys
21
In manufacturing, Black employees were 9.8% in 2022
22
Women in sales roles were 39.6% in pharma 2023
23
In 2021, 27.5% of regulatory affairs roles held by minorities
24
Caregivers (primarily women) were 28.4% of workforce in 2022
25
In 2023, 41.7% of informatics roles women-dominated
26
Rural-origin employees 11.2% underrepresented in 2022
27
In 2023, 34.8% of QA roles by Hispanic employees
28
Low-income background hires rose to 15.6% in 2022
29
In STEM pipeline, 46.9% women entering life sciences PhDs 2023
Interpretation
Workforce Demographics Interpretation
The data reveals a persistent, almost gravitational leak in our talent pipeline, where promising entry-level diversity succumbs to narrowing representation at higher echelons, suggesting that while the industry is increasingly adept at inviting people to the party, it remains clumsy at asking them to dance in positions of real influence.
report visual · Key figures
DEI pay gaps persist in life sciences
Headline pay-disparity metrics show meaningful gaps across gender and multiple underrepresented groups.
18%
Women earned 18% less than men in equivalent life sciences roles in 2022
25.4%
Black employees faced a 25.4% pay gap versus white counterparts in biotech 2023
12.1%
LGBTQ+ employees reported 12.1% lower median pay in 2023 survey
19.3%
Disabled workers earned 19.3% less in medtech 2022
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Diversity Equity And Inclusion In The Life Science Industry Statistics. Gitnux. https://gitnux.org/diversity-equity-and-inclusion-in-the-life-science-industry-statistics
MLA
Sophie Moreland. "Diversity Equity And Inclusion In The Life Science Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/diversity-equity-and-inclusion-in-the-life-science-industry-statistics.
Chicago
Sophie Moreland. 2026. "Diversity Equity And Inclusion In The Life Science Industry Statistics." Gitnux. https://gitnux.org/diversity-equity-and-inclusion-in-the-life-science-industry-statistics.
Sources & references
7 datasets cited across this report · attribution is report-level